About this trial
The goal of this multi-center observational study is to learn about the effectiveness of magnetocardiography in rapid and accurate identification of ischemia in patients with suspected NSTE-ACS.
Eligibility criteria
Qualifiers
Age 18 years or older;
Patients with symptoms of myocardial ischemia such as angina who are suspected to NSTE-ACS and proposed to undergo CAG or coronary CTA;
Signed informed consent.
Disqualifiers
Patients with ST-elevation myocardial infarction (STEMI);
Patients with Non-ischemic dilated cardiomyopathy, or hypertrophic cardiomyopathy, or moderate or severe valvular disease;
Patients with Hemodynamic instability (systolic blood pressure<90 mmHg, or who requires vasoactive drugs), or patients with tachyarrhythmia, Ⅱ degree atrioventricular block and above that have not returned to normal;
Patients who have severe renal abnormality with eGFR <30 ml/min, or patients who are on dialysis;
Trial design
Treatments tested in this trial
- Magnetocardiography
Treatment groups
Sponsors and collaborators
Qilu Hospital of Shandong University
Lead sponsor
Linyi People's Hospital
Collaborator
Weifang People's Hospital
Collaborator
Jining First People's Hospital
Collaborator
Weihai Central Hospital
Collaborator
The First Affiliated Hospital with Nanjing Medical University
Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborator
First Affiliated Hospital Xi'an Jiaotong University
Collaborator
First People's Hospital of Hangzhou
Collaborator
Chongqing Emergency Medical Center
Collaborator
Guangdong Provincial Hospital of Traditional Chinese Medicine
Collaborator
Qianfoshan Hospital
Collaborator
Heze Municipal Hospital
Collaborator
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Collaborator